Please provide your email address to receive an email when new articles are posted on . The age of biosimilars has come for gastroenterology. This includes interchangeable products, three of which are ...

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

The FDA approved Nufymco as an interchangeable biosimilar to Lucentis, making it the second approved ranibizumab biosimilar in the U.S. from Formycon and Bioeq, the companies announced in a press ...

The Food and Drug Administration has approved five biosimilars since 2010 — none of which are designated as “interchangeable” to the biologic drug they mimic, reports Regulatory Focus. The FDA defines ...

Findings showed equivalent efficacy in change from baseline in weekly itch severity score between omalizumab-igec 300mg and Xolair 300mg. The Food and Drug Administration (FDA) has approved Omlyclo ® ...

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

The Biosimilars Council applauded the bipartisan introduction of the Biosimilar Red Tape Elimination Act in the U. S. House of Representatives. The legislation, sponsored by Representatives Pfluger (R ...

(RTTNews) - The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major ...

RIDGEFIELD, Conn., Oct. 2, 2023 /PRNewswire/ -- Boehringer Ingelheim announced today that Adalimumab-adbm injection, the company's interchangeable* biosimilar to Humira ® (adalimumab), is now ...

The Federal Trade Commission submitted a comment supporting the Food and Drug Administration’s draft guidance regarding interchangeable biosimilar drugs that can be substituted for brand-name biologic ...